Navigation Links
ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR

LOS ANGELES--(BUSINESS WIRE)--Apr 17, 2007 - ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today the presentation of preclinical data strongly supportive of the development of an oral form of ZIO-101. Specifically, ZIO-101 demonstrates very high bioavailability when administered orally; in addition it evidences anti-angiogenic activity that is particularly well suited to oral administration. These data were presented in two separate posters today at the American Association of Cancer Research (AACR) meeting being held in Los Angeles.

Philip Komarnitsky, M.D., Ph.D., of ZIOPHARM, and colleagues presented data showing that the administration of ZIO-101 results in dramatically reduced new blood vessel formation in a mouse model of angiogenesis. Anti-angiogenic therapy that utilizes lower doses of the administered drug given over sustained periods of time is particularly well suited to drugs that can be orally administered. Data from pharmacokinetic analysis of orally administered ZIO-101 in animals showed very high bioavailability.

Lawrence Boise, Ph.D., from the University of Miami, and colleagues also presented additional data supporting a ZIO-101 mechanism of action that is distinct from that of arsenic trioxide, an inorganic arsenic that is currently approved for the treatment of a rare form of leukemia and used in the treatment of advanced multiple myeloma. Differences in the way the two drugs activate genes and in their mechanisms of action suggest that ZIO-101 is likely to be active against cancer cells that are resistant to arsenic trioxide.

"These preclinical data are strongly supportive of the Company's development strategy for both oral and IV ZIO-101," commented Jonathan Lewis, M.D., Ph.D., Chief Executive Officer. "ZIO-101 is currently in three separate phase II trials in blood and solid cancers and we expect to initiate clinical study with an oral form in the second half of 2007."'"/>




Page: 1 2 3

Related medicine technology :

1. ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR
3. ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR
4. ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
7. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
8. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
9. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ZIOPHARM Presents Data Highlighting Oral ZIO AACR
(Date:10/25/2014)... Research and Markets  has announced the addition of ... Global Forecast to 2019" report to their offering. ... equipment market is categorized on the basis of product ... expected to register the highest growth rate in the ... 2019). This high growth is attributed to the rising ...
(Date:10/25/2014)... 2014 Research and Markets ... the "Global and Chinese Hemodialysis Concentrates Industry ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , Global ... a professional and in-depth study on the current ... focus on the Chinese situation. The ...
(Date:10/25/2014)... , Oct. 24, 2014 In conjunction ... quarter 2014 financial results press release, you are invited ... broadcast live over the internet on Monday, November 3, ... Time). A live audio webcast of the ... http://www.durect.com and clicking "Investor Relations."  If you ...
Breaking Medicine Technology:Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Global and Chinese Hemodialysis Concentrates Industry Report 2014 2Global and Chinese Hemodialysis Concentrates Industry Report 2014 3DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
... Ind., Feb. 24, 2011 Symmetry Medical Inc. (NYSE: ... orthopaedic device industry and other medical markets, announced fourth quarter and ... 2011.Fourth QuarterTotal Year (In millions, except per share data) , ... 96.0 , $ 76.4 , 26%$ 360.8 , $ 365.9 , ...
... Mass. and SYDNEY, Feb. 24, 2011 HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced revenues of $20.9 million for the fourth ... million in revenues for the fourth quarter of 2009, ...
Cached Medicine Technology:Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 2Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 3Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 4Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 5Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 6Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 7Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 8Symmetry Medical Reports Fourth Quarter and Full Year 2010 Financial Results 9HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 2HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 3HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 4HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 5HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009 6
(Date:10/25/2014)... Market Research Report on ... is a professional and in-depth market survey ... The report firstly reviews the basic information ... and manufacturing technology. The report then explores ... Diagnostics listing their product specification, capacity, Production ...
(Date:10/25/2014)... October 25, 2014 Mesothelioma researchers are ... to receive pemetrexed (Alimta), after his combination drug therapy ... full story , just posted on the Surviving Mesothelioma ... Tokushukai Medical Center in Japan suggests that “maintenance therapy” ... patients who cannot tolerate higher doses of cisplatin. ...
(Date:10/25/2014)... 24, 2014 (HealthDay News) -- Not getting the right ... colitis, a new study suggests. Those who sleep ... hours per night may be more prone to developing ... researchers report. The study authors concluded that duration and ... among patients with inflammatory bowel diseases. "Both short ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 ... spot increased risks for certain cancers, one might think that ... But a new study suggests that, at least with colon ... their genes doubled their risk of colon cancer were no ... "It didn,t make any difference, not at all," said ...
(Date:10/22/2014)... On October 22, CBS will air an ... both fictional and real. The Charles E Holman ... to advocacy and philanthropy in the battle against Morgellons ... to impart truth and clarity about this misunderstood and ... misconceptions about Morgellons Disease (MD) and most ...
Breaking Medicine News(10 mins):Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3
... fibers, researchers say, , THURSDAY, Aug. 20 (HealthDay News) ... condition that can impair fertility, requires no surgery and ... experts said the accuracy of the new approach, which ... be replicated, which the researchers also acknowledged. , Until ...
... ... in full swing. Texas and Southwestern Cattle Raisers Association (TSCRA) Insurance Services is helping its ... equipping them with important preventative care measures that will not only save them money, but ... ...
... ... 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD). , ... Horsham, PA, USA (Vocus) August 20, ... Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD). , , , , ...
... List of cities and times below. Team will travel in a Motor ... filming comedy commercials against "Obama,s Death Care," including costumes, props and images. ... Aug. 20 The following was released today by Randall Terry, Director, Operation ... see the rage expressed at ,town hall meetings., However, much of this ...
... , , WHITE PLAINS, N.Y. ... August is National Immunization Awareness Month, and while ... The "Sounds of Pertussis", a campaign from the March of Dimes ... educating adults about pertussis prevention, so that they can keep themselves ...
... , WASHINGTON, Aug. 20 The American Red Cross ... the beach along the U.S. East Coast this weekend as experts ... the shore. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) ... Three storm with winds blowing up to 125 mph, and experts ...
Cached Medicine News:Health News:New Way Found to Diagnose Endometriosis 2Health News:New Way Found to Diagnose Endometriosis 3Health News:TSCRA Insurance Services Shares Importance of Back-to-School Preventative Health Care 2Health News:TSCRA Insurance Services Shares Importance of Back-to-School Preventative Health Care 3Health News:DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks 2Health News:Healthcare and Abortion: Randall Terry Leads Protests and Press Conferences in 10 Cities in Five States 2Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 2Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 3Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 4Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 5Health News:Video: 'Sounds of Pertussis' Campaign Urges Adults to Take Action During National Immunization Awareness Month 6Health News:American Red Cross Provides Safety Tips for Rip Tides Caused by Hurricane Bill 2
... a comprehensive, authoritative drug reference to ... overdose management, Canadian drug names, OTC ... drug references and tools is included ... (ED, PRIMARY CARE PLUS, CRC, RN, ...
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy....
... the latest in scientific clinical trial activity ... knowledge resources from CenterWatch. This highly valuable ... monitor and stay abreast of medical breakthroughs ... Clinical Trials, Clinical Trial Results, Newly Approved ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
Medicine Products: